Family · Pharmaceutical analytical standards
Daprodustat
An oral inhibitor of HIF prolyl hydroxylase that boosts the body's own production of erythropoietin: approved in Japan in 2020 and in the United States in 2023, it is used for anaemia of chronic kidney disease. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It acts on the system cells use to sense oxygen, a discovery awarded the 2019 Nobel Prize in Medicine: in effect it makes the body believe it is at high altitude.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
